×
About 90,392 results

ALLMedicine™ Coronary Artery Disease Center

Research & Reviews  43,299 results

Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricul...
https://doi.org/10.1016/j.jacc.2020.07.047
Journal of the American College of Cardiology; Park S, Ahn JM et. al.

Sep 18th, 2020 - Left main coronary artery (LMCA) disease is associated with high mortality and morbidity due to a large area of jeopardized myocardium. However, the optimal revascularization strategy for patients with LMCA disease and left ventricular dysfunction...

Revascularization Choices for Left Main Coronary Artery Disease: Does Left Ventricular ...
https://doi.org/10.1016/j.jacc.2020.08.005
Journal of the American College of Cardiology; Stone GW

Sep 18th, 2020 - Revascularization Choices for Left Main Coronary Artery Disease: Does Left Ventricular Function Matter?|2020|Stone GW,|

The Neutrophil to Lymphocyte Ratio (NLR) Is Associated With Residual Syntax Score in Pa...
https://doi.org/10.1177/0003319720958556
Angiology Kahraman S, Agus HZ et. al.

Sep 18th, 2020 - The neutrophil to lymphocyte ratio (NLR) predicts adverse clinical outcomes in several cardiovascular diseases. Our aim was to investigate the association of residual SYNTAX score (rSS) with the NLR in patients (n = 613) with ST-segment elevation ...

Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary ...
https://doi.org/10.1080/03007995.2020.1825364
Current Medical Research and Opinion; Li J, Qiu H et. al.

Sep 18th, 2020 - Aims: The efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains uncertain. The purpose of this study was to compare the efficacy and ...

Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidati...
https://doi.org/10.1161/ATVBAHA.120.315156
Arteriosclerosis, Thrombosis, and Vascular Biology; Weaver JC, Ullah I et. al.

Sep 17th, 2020 - Atherosclerotic coronary artery disease is well recognised as an inflammatory disorder that is also influenced by oxidative stress. β2-GPI (β-2-glycoprotein-I) is a circulating plasma protein that undergoes post-translational modification and exis...

see more →

Guidelines  127 results

ACR Appropriateness Criteria® Chest Pain-Possible Acute Coronary Syndrome.
https://doi.org/10.1016/j.jacr.2020.01.027
Journal of the American College of Radiology : JACR; , Batlle JC et. al.

May 5th, 2020 - Chest pain is a frequent cause for emergency department visits and inpatient evaluation, with particular concern for acute coronary syndrome as an etiology, since cardiovascular disease is the leading cause of death in the United States. Although ...

The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics
https://www.sciencedirect.com/science/article/abs/pii/S0002870319302698?via%3Dihub
American Heart Journal; Nidorf SM,et al

Nov 30th, 2019 - Because patients with stable coronary artery disease are at continued risk of major atherosclerotic events despite effective secondary prevention strategies, there is a need to continue to develop additional safe, effective and well-tolerated ther...

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
https://www.nejm.org/doi/full/10.1056/NEJMoa1909406

Sep 27th, 2019 - BACKGROUND Long-term outcomes after percutaneous coronary intervention (PCI) with contemporary drug-eluting stents, as compared with coronary-artery bypass grafting (CABG), in patients with left main coronary artery disease are not clearly establi...

Lipoprotein(a): The Next Promising CVD Risk Assessment Tool and Prevention Target Among the High-risk Population
https://www.acc.org/latest-in-cardiology/articles/2019/09/17/15/02/lipoprotein-a

Sep 17th, 2019 - After low density lipoprotein cholesterol (LDL-C) has been targeted to reduce cardiovascular disease (CVD) risk, other novel lipid biomarkers have become the center of attention of investigation, and on-going clinical trials are targeting these li...

HeartFlow Announces FDA Clearance for HeartFlow Planner
https://www.heartflow.com/newsroom/heartflow-announces-fda-clearance-for-heartflow-planner

Sep 11th, 2019 - HeartFlow, Inc. today announced that it has obtained clearance from the U.S. Food and Drug Administration (FDA) for the HeartFlow Planner, a non-invasive, real-time virtual modeling tool for coronary artery disease (CAD) intervention. The HeartFlo...

see more →

Drugs  699 results see all →

Clinicaltrials.gov  44,709 results

Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricul...
https://doi.org/10.1016/j.jacc.2020.07.047
Journal of the American College of Cardiology; Park S, Ahn JM et. al.

Sep 18th, 2020 - Left main coronary artery (LMCA) disease is associated with high mortality and morbidity due to a large area of jeopardized myocardium. However, the optimal revascularization strategy for patients with LMCA disease and left ventricular dysfunction...

Revascularization Choices for Left Main Coronary Artery Disease: Does Left Ventricular ...
https://doi.org/10.1016/j.jacc.2020.08.005
Journal of the American College of Cardiology; Stone GW

Sep 18th, 2020 - Revascularization Choices for Left Main Coronary Artery Disease: Does Left Ventricular Function Matter?|2020|Stone GW,|

The Neutrophil to Lymphocyte Ratio (NLR) Is Associated With Residual Syntax Score in Pa...
https://doi.org/10.1177/0003319720958556
Angiology Kahraman S, Agus HZ et. al.

Sep 18th, 2020 - The neutrophil to lymphocyte ratio (NLR) predicts adverse clinical outcomes in several cardiovascular diseases. Our aim was to investigate the association of residual SYNTAX score (rSS) with the NLR in patients (n = 613) with ST-segment elevation ...

Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary ...
https://doi.org/10.1080/03007995.2020.1825364
Current Medical Research and Opinion; Li J, Qiu H et. al.

Sep 18th, 2020 - Aims: The efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains uncertain. The purpose of this study was to compare the efficacy and ...

Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidati...
https://doi.org/10.1161/ATVBAHA.120.315156
Arteriosclerosis, Thrombosis, and Vascular Biology; Weaver JC, Ullah I et. al.

Sep 17th, 2020 - Atherosclerotic coronary artery disease is well recognised as an inflammatory disorder that is also influenced by oxidative stress. β2-GPI (β-2-glycoprotein-I) is a circulating plasma protein that undergoes post-translational modification and exis...

see more →

News  1,471 results

AstraZeneca's heart drug gets FDA nod
https://www.reuters.com/article/us-astrazeneca-fda/astrazenecas-heart-drug-gets-fda-nod-idUSKBN2381FJ

Jun 1st, 2020 - FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble (Reuters) - AstraZeneca Plc said on Monday the U.S. Food and Drug Administration has approved its drug for reducing the ri...

A Case-Based Review of Iron Overload With an Emphasis on Porphyria Cutanea Tarda, Hepatitis C, C282Y Heterozygosity, and Coronary Artery Disease
https://www.mdedge.com/fedprac/article/216484/hepatitis/case-based-review-iron-overload-emphasis-porphyria-cutanea-tarda/page/0/4?channel=314

Jan 31st, 2020 - Iron Overload and Cardiovascular Risk In 1987, a Framingham cohort of > 2,800 patients showed a higher incident of CAD in postmenopausal women when compared with premenopausal women. 12 In the 1980s, Sullivan hypothesized that the reason for higher.

Why STEMI patients benefit from PCI of nonculprit lesions
https://www.mdedge.com/jcomjournal/article/215900/cardiology/why-stemi-patients-benefit-pci-nonculprit-lesions?channel=194
Bruce Jancin

Jan 22nd, 2020 - PHILADELPHIA – Nearly half of patients with ST-elevation MI and multivessel coronary artery disease in the landmark COMPLETE trial had an obstructive coronary lesion with vulnerable plaque morphology in a segment far from the culprit lesion, Natal.

The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics
https://www.sciencedirect.com/science/article/abs/pii/S0002870319302698?via%3Dihub
American Heart Journal; Nidorf SM,et al

Nov 30th, 2019 - Because patients with stable coronary artery disease are at continued risk of major atherosclerotic events despite effective secondary prevention strategies, there is a need to continue to develop additional safe, effective and well-tolerated ther...

Stress echo could predict PCI efficacy in stable CAD
https://www.mdedge.com/cardiology/article/212446/cad-atherosclerosis/stress-echo-could-predict-pci-efficacy-stable-cad?channel=39313
Bianca Nogrady

Nov 16th, 2019 - Dobutamine stress echocardiography could be used to predict which patients with single-vessel stable coronary artery disease are most likely to benefit from percutaneous coronary intervention, according to secondary analysis of data from the ORBIT.

see more →

Patient Education  87 results see all →